Search Result "p100α"
The NF-kB Pathway as a Potential Target for Autoimmune Disease Therapy
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 2 Year: 2004 Page: 2827-2837
Author(s): Susanne Bacher, M. Lienhard Schmitz
NF-κB Signaling and Carcinogenesis
Journal: Current Pharmaceutical Design
Volume: 13 Issue: 5 Year: 2007 Page: 447-462
Author(s): Takashi Okamoto, Takaomi Sanda, Kaori Asamitsu
NF-κB in Neurons-Mechanisms and Myths
Ebook: Transcription Factors CREB and NF-kB: Involvement in Synaptic Plasticity and Memory Formation
Volume: 1 Year: 2012
Author(s): Steven W. Barger,Xianrong R. Mao
Doi: 10.2174/978160805257811201010113
NF-κB in Anti-Inflammatory Activity of Probiotics: An Update
Journal: Current Immunology Reviews (Discontinued)
Volume: 12 Issue: 2 Year: 2016 Page: 74-82
Author(s): Ana Virginia Rodriguez,Milagros Griet
Modulation of Gene Transcription by Natural Products - A Viable Anticancer Strategy
Journal: Current Pharmaceutical Design
Volume: 13 Issue: 2 Year: 2007 Page: 2744-2750
Author(s): M. DIncalci, D. Brunelli, E. Marangon, M. Simone, M. Tavecchio, A. Gescher, R. Mantovani
NF-κB Signaling: Multiple Angles to Target OA
Journal: Current Drug Targets
Volume: 11 Issue: 5 Year: 2010 Page: 599-613
Author(s): Kenneth B. Marcu, Miguel Otero, Eleonora Olivotto, Rosa Maria Borzi, Mary B. Goldring
From Test Tube to Clinical Trial; Promising Herbs with NF-κB and COX- 2 Activity
Journal: Current Immunology Reviews (Discontinued)
Volume: 10 Issue: 2 Year: 2014 Page: 82-98
Author(s): Frank Wilkinson,Diana R. Cundell
Cardiac Role of the Transcription Factor NF-κB
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 8 Issue: 2 Year: 2008 Page: 153-160
Author(s): Salomon Hernandez Gutierrez, Manuel Ramos Kuri, Emilio Rojas del Castillo
Transcription Factor Profiling Shows New Ways Towards New Treatment Options of Cutaneous T cell lymphomas
Journal: Current Drug Discovery Technologies
Volume: 4 Issue: 1 Year: 2007 Page: 24-30
Author(s): Udo Dobbeling
Transcription Factors in Cancer
Ebook: Molecular Targets and Cancer Therapeutics (Part 1)
Volume: 1 Year: 2023
Author(s):
Doi: 10.2174/9789815080384123010010